Iradimed (IRMD) Stock Chart & Stock Price History $52.28 -0.72 (-1.36%) (As of 03:37 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Iradimed Stock Price Performance 5 Day Performance+0.70%1 Month Performance+3.82%3 Month Performance+9.39%6 Month Performance+25.27%Year-To-Date Performance+11.65%1 Year Performance+18.73% Receive IRMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iradimed and its competitors with MarketBeat's FREE daily newsletter. Email Address Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown. IRMD Stock Chart for Wednesday, December, 18, 2024 IRMD Chart by TradingView Iradimed Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$53.18$53.00-0.34%$53.67$51.7884,070 shs$671.67 million12/16/2024$52.63$53.18+1.05%$54.15$52.6333,138 shs$673.95 million12/13/2024$54.43$52.63-3.31%$54.22$52.2972,108 shs$666.82 million12/12/2024$55.19$54.43-1.38%$55.03$53.5834,303 shs$689.63 million12/11/2024$55.30$55.19-0.20%$56.39$55.11133,053 shs$699.26 million12/10/2024$54.71$55.30+1.08%$56.50$54.2940,129 shs$700.65 million Get the Latest News and Ratings for IRMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iradimed and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$54.18$54.71+0.98%$55.79$54.1332,020 shs$693.18 million12/06/2024$54.48$54.18-0.55%$54.78$53.8426,628 shs$686.46 million12/05/2024$54.72$54.48-0.44%$55.86$54.1833,270 shs$690.26 million12/04/2024$53.64$54.72+2.01%$55.18$53.1341,366 shs$693.47 million12/03/2024$53.84$53.64-0.36%$53.88$53.1118,426 shs$679.62 million12/02/2024$53.93$53.84-0.18%$54.50$53.3629,204 shs$682.09 million11/29/2024$53.58$53.93+0.65%$54.09$53.5211,592 shs$683.29 million11/28/2024$53.58$53.58$53.79$52.6526,413 shs$678.86 million11/27/2024$52.75$53.58+1.57%$53.79$52.8526,413 shs$678.86 million11/26/2024$53.39$52.75-1.20%$53.25$51.9832,282 shs$668.34 million11/25/2024$53.23$53.39+0.30%$54.27$53.0065,748 shs$676.45 million11/22/2024$53.23$53.23$53.81$52.6542,801 shs$674.58 million11/21/2024$52.08$53.23+2.21%$54.81$52.0741,606 shs$674.42 million11/20/2024$51.25$52.08+1.62%$52.18$51.0151,254 shs$659.85 million11/19/2024$51.05$51.25+0.39%$51.66$50.4151,450 shs$649.34 million11/18/2024$51.99$51.05-1.81%$52.50$50.9565,670 shs$646.96 million Related Companies ENOV Stock Chart WRBY Stock Chart CNMD Stock Chart TNDM Stock Chart TMDX Stock Chart SLNO Stock Chart RXST Stock Chart INMD Stock Chart MDXG Stock Chart ESTA Stock Chart Receive IRMD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Iradimed and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IRMD) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iradimed Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Iradimed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
